| Year |
Citation |
Score |
| 2022 |
Jiang H, Yu X, Li N, Kong M, Ma Z, Zhou D, Wang W, Wang H, Wang H, He K, Li Z, Lu Y, Zhang J, Zhao K, Zhang Y, et al. Efficacy and safety of neoadjuvant sintilimab, oxaliplatin and capecitabine in patients with locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: early results of a phase 2 study. Journal For Immunotherapy of Cancer. 10. PMID 35296556 DOI: 10.1136/jitc-2021-003635 |
0.545 |
|
| 2021 |
Zhang J, Jin N, Ji N, Chen X, Shen Y, Pan T, Li L, Li S, Zhang W, Huo F. The Encounter of Biomolecules in Metal-Organic Framework Micro/Nano Reactors. Acs Applied Materials & Interfaces. PMID 34369162 DOI: 10.1021/acsami.1c09660 |
0.398 |
|
| 2021 |
Lu J, Ding Y, Chen Y, Jiang J, Chen Y, Huang Y, Wu M, Li C, Kong M, Zhao W, Wang H, Zhang J, Li Z, Lu Y, Yu X, et al. Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets. Nature Communications. 12: 3946. PMID 34168152 DOI: 10.1038/s41467-021-24170-0 |
0.565 |
|
| 2021 |
Wang H, Ding Y, Chen Y, Jiang J, Chen Y, Lu J, Kong M, Mo F, Huang Y, Zhao W, Fang P, Chen X, Teng X, Xu N, Lu Y, ... ... Zhang J, et al. A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. PMID 34095982 DOI: 10.1007/s10120-021-01201-9 |
0.564 |
|
| 2020 |
Zhang J, Xiao C, Feng Z, Gong Y, Sun B, Li Z, Lu Y, Fei X, Wu W, Sun X, Teng L. SOX4 promotes the growth and metastasis of breast cancer. Cancer Cell International. 20: 468. PMID 33005101 DOI: 10.1186/s12935-020-01568-2 |
0.589 |
|
| 2020 |
Zhang J, Huang JZ, Zhang YQ, Zhang X, Zhao LY, Li CG, Zhou YF, Wei H, Yu J. Microtubule associated protein 9 inhibits liver tumorigenesis by suppressing ERCC3. Ebiomedicine. 53: 102701. PMID 32151798 DOI: 10.1016/J.Ebiom.2020.102701 |
0.668 |
|
| 2020 |
Li G, Zhang J, Xu Z, Li Z. ERα36 as a Potential Therapeutic Target for Tamoxifen-Resistant Breast Cancer Cell Line Through EGFR/ERK Signaling Pathway. Cancer Management and Research. 12: 265-275. PMID 32021441 DOI: 10.2147/CMAR.S226410 |
0.574 |
|
| 2019 |
Chen X, Yang Y, Wang W, Han B, Qi M, Geng S, Xu J, Zhang Q, Wang X, Chen S, Shi K, Ke X, Zhang J. Prognostic significance of the presence of intraductal carcinoma of the prostate and bone metastasis in needle biopsy for prostate carcinoma patients with Grade Group 5. Pathology, Research and Practice. 152693. PMID 31734052 DOI: 10.1016/J.Prp.2019.152693 |
0.409 |
|
| 2019 |
Li N, Li Z, Zhang L, Shi H, Li J, Zhang J, Zhang Z, Dang F. One-step fabrication of bifunctional self-assembled oligopeptides anchored magnetic carbon nanoparticles and their application in copper (II) ions removal from aqueous solutions. Journal of Hazardous Materials. 382: 121113. PMID 31479827 DOI: 10.1016/j.jhazmat.2019.121113 |
0.51 |
|
| 2019 |
Wang X, Qi M, Zhang J, Sun X, Guo H, Pang Y, Zhang Q, Chen X, Zhang R, Liu Z, Liu L, Hao X, Han B. Differential response to neoadjuvant hormonal therapy in prostate cancer: Predictive morphological parameters and molecular markers. The Prostate. PMID 30825345 DOI: 10.1002/Pros.23777 |
0.417 |
|
| 2017 |
Zhang J, Zhang X, Zhao X, Jiang M, Gu M, Wang Z, Yue W. DKK1 promotes migration and invasion of non-small cell lung cancer via β-catenin signaling pathway. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 39: 1010428317703820. PMID 28677426 DOI: 10.1177/1010428317703820 |
0.423 |
|
| 2013 |
Li G, Zhang J, Jin K, He K, Zheng Y, Xu X, Wang H, Wang H, Li Z, Yu X, Teng X, Cao J, Teng L. Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells. Molecular Oncology. 7: 611-24. PMID 23499324 DOI: 10.1016/j.molonc.2013.02.001 |
0.573 |
|
| 2012 |
Zhang J, Li G, Li Z, Yu X, Zheng Y, Jin K, Wang H, Gong Y, Sun X, Teng X, Cao J, Teng L. Estrogen-independent effects of ER-α36 in ER-negative breast cancer. Steroids. 77: 666-73. PMID 22402113 DOI: 10.1016/j.steroids.2012.02.013 |
0.571 |
|
| Show low-probability matches. |